
Balaji Amines Q4 FY26 Results Preview: Revenue, PAT & EBITDA Growth Expectations
Updated: 13 Mar 2026 • 4:37 pm
Posted by:

Balaji Amines Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Balaji Amines was listed on the National Stock Exchange (NSE) on 05-Apr-2007. Balaji Amines share has its face value of 2 per share, and its NSE symbol is BALAMINES. The company operates in the Chemicals sector and primarily belongs to the Specialty Chemicals industry.
Balaji Amines Q4 Results 2026 Preview
- Balaji Amines Q4 FY26 revenue is expected to be around Moderate Growth Expected, representing a 13% YoY increase compared to the same quarter last year.
- Profit After Tax, or PAT, is projected to rise 14% YoY.
- EBITDA to rise 15%.
- Balaji Amines is expected to show Moderate Growth Expected in its revenue.
Click and Sign Up to Get Live Updates on Q4 Results
Balaji Amines Share Performance
- Over the past six months, Balaji Amines share price has negative by -8% to 1,008.40.
- Moreover, over the past year, the stock has positive by 34%
- Despite this weak short-term performance, Balaji Amines stock has delivered a financially sound 319% return over the past 5 years.
- As of today, 13-03-2026, the Balaji Amines share price is trading at 1,008.40 per share.
Key Factors to Watch for Balaji Amines Q4 Results FY26
- Revenue Growth & Segment Performance – Focus on topline growth in the Specialty Chemicals industry within the Chemicals sector.
- Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
- Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
- Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
- Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.
About Balaji Amines
Balaji Amines operates in the chemicals segment and focuses on expanding its product portfolio, improving operational efficiency, and strengthening distribution across domestic and export markets. The company continues to focus on growth through innovation, capacity expansion, and improving margins while maintaining a strong presence in its core business segments.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Final Thoughts
Balaji Amines is gear up to announce its Q4 FY26 results. Analysts expect 13% revenue growth, a 14% rise in PAT, and a 15% rise in EBITDA. Balaji Amines focuses on revenue growth from order execution, margin improvement, a strong order book, and management.
Stay informed with Univest blogs to get real-time updates on Balaji Amines Q4 results FY26.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Advent Hotels International Q4 FY26 Results Preview
Advani Hotels Q4 FY26 Results Preview & Outlook
Advance Agrolife Q4 FY26 Results Preview & Outlook
Advait Energy Transitions Q4 FY26 Results Preview
Recent Articles

Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
30 October 2026

Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
30 October 2026

Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
30 October 2026

Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
Asian Paints Share Price After Q2 Results: Profit Up 7%, but Price Hikes Are Yet to Brighten Margins

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





